Zomedica Corp. (AMEX:ZOM) price is hovering higher on Monday, September 13, jumping 0.23% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $0.56, with intraday deals fluctuating between $0.56 and $0.60. The company’s 5Y monthly beta was ticking 0.31. Taking into account the 52-week price action we note that the stock hit a 52-week high of $2.91 and 52-week low of $0.06. The stock added 8.74% on its value in the past month.
Zomedica Corp., which has a market valuation of $585.10 million, is expected to release its quarterly earnings report Nov 10, 2021 – Nov 15, 2021. Analysts tracking ZOM have forecast the quarterly EPS to shrink by 0 per share this quarter, while the same analysts predict the annual EPS to hit $0 for the year 2021 and up to $0 for 2022.
Staying with the analyst view, there is a consensus estimate of $4.43 million for the company’s annual revenue in 2021.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give ZOM a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 1 analysts have assigned ZOM a recommendation rating as follows: 0 rate it as a Hold; 1 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Zomedica Corp. (ZOM) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that ZOM’s price is at present 0.60% off the SMA20 and -6.20% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 46.59, with weekly volatility standing at 7.65%. The indicator jumps to 9.76% when calculated based on the past 30 days. Zomedica Corp. (AMEX:ZOM)’s beta value is holding at 0.31, while the average true range (ATR) indicator is currently reading 0.05. Considering analysts have assigned the stock a price target range of $1.20-$1.20 as the low and high respectively, we find the trailing 12-month average consensus price target to be $1.20. Based on this estimate, we see that today’s price at last check is roughly -110.53% off the estimated low and -110.53% off the forecast high. Investors will no doubt be excited to see the share price fall to $1.20, which is the median consensus price, and at that level ZOM would be -110.53% from recent price.
An analysis of the Zomedica Corp. (AMEX:ZOM) stock in terms of its daily trading volume indicates that the 3-month average is 28.49 million.
Current records show that the company has 973.66M in outstanding shares. The insiders’ percentage holdings are 2.61% of outstanding shares while the percentage share held by institutions stands at 12.56%. But the 145.01% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.